Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study

scientific article published on 20 August 2003

Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00417-003-0724-7
P2888exact matchhttps://scigraph.springernature.com/pub.10.1007/s00417-003-0724-7
P698PubMed publication ID12928902

P2093author name stringRainer Sundmacher
Thomas Reinhard
Klaus Mayer
Adina Voiculescu
Alexander Reis
P2860cites workThe novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivoQ28379426
Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trialQ35307865
Immune reactions following keratoplastyQ36462474
Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trialQ43693514
Postoperative complications of penetrating keratoplasty in herpes infected eyes. Differential diagnosis, therapy and prognostic significanceQ44695403
The use of cyclosporine in high-risk keratoplasty.Q44857425
Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatmentQ67298323
Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survivalQ68190930
[Clinical types of immunologic transplant reactions following perforating keratoplasty]Q68749684
[Oral acyclovir therapy of virologically proven intraocular herpes simplex virus infections]Q70176672
Corneal endotheliitis. Definition and clinical classificationQ70356826
Four years' experience with triple procedures in herpes-afflicted eyesQ70690814
Recurrent herpetic keratitis in penetrating keratoplastyQ70867555
A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitisQ72066241
[Herpes simplex keratitis. On the long-term prognosis of first transplants after penetrating keratoplasty]Q72283271
[Acute and chronic immune reactions after penetrating keratoplasty with normal immune risk]Q73474684
[Preventive systemic cyclosporin A after keratoplasty at increased risk for immune reactions as the only elevated risk factor]Q73795165
Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study GroupQ74098387
Oral acyclovir after penetrating keratoplasty for herpes simplex keratitisQ77334676
P433issue12
P921main subjectaciclovirQ147101
eye diseaseQ3041498
P304page(s)1051-1054
P577publication date2003-08-20
P1433published inGraefe's Archive for Clinical and Experimental OphthalmologyQ15757667
P1476titleSynergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study
P478volume241

Reverse relations

cites work (P2860)
Q79197070Clear graft survival and immune reactions following emergency keratoplasty
Q81536052Decreased active TGF-beta2 levels in the aqueous humour during immune reactions following penetrating keratoplasty
Q33289884HLA B27 seems to promote graft failure following penetrating keratoplasties for herpetic corneal scars
Q44712926Immunomodulation in penetrating keratoplasty. Current status and perspectives
Q92093112Literature review and suggested protocol for prevention and treatment of corneal graft rejection
Q36085873MMF and eye disease
Q38778422Management of High-risk Corneal Transplantation
Q41882382Practice patterns for herpes simplex keratitis: A survey of ophthalmologists in Gulf Coast countries
Q34772117Prophylaxis and management of complications in penetrating keratoplasty
Q38904800Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation
Q26764905Systemic Immunosuppression in High-Risk Penetrating Keratoplasty: A Systematic Review
Q85059550Tonic-clonic seizure following combined treatment of mycophenolate mofetil and acyclovir
Q80044887[Systemic immunosuppressives after penetrating keratoplasty]

Search more.